Development code · Small Molecule
TAK-861
TAK-861 is a development code for Oveporexton, developed by Takeda Pharmaceutical Company Limited.
- Status
- Filed (NDA) for Narcolepsy
- Mechanism
- OX2R Agonist
Programs
- Oveporexton for NarcolepsyFiled (NDA)Active
Also known as
- Oveporexton
- 2460722-04-5